Recently released data on infant deaths across states in India has thrown up surprising results, leaving health experts puzzled. Average infant mortality rate for the country as a whole stood at 50 in 2009, down by 30% compared to a decade ago. The rate is much higher than developed countries but the pace at which it is declining is encouraging. But the surprises lurk in state level data. Three states -...
More »SEARCH RESULT
Binayak Sen on Plan panel committee by Aarti Dhar
Within weeks of getting bail from the Supreme Court in connection with charges of sedition, human rights activist Binayak Sen has been made member of the Planning Commission's Steering Committee on Health, which will advise the panel on the Twelfth Five-Year Plan (2012-2017). Binayak Sen, who was released on bail from the Raipur jail last month, will, based on his experience of having worked as a paediatrician in Chhattisgarh's tribal belt,...
More »Health budget may go up by 2% by Kounteya Sinha
India plans to increase its allocation for health to 2%-3% of its GDP over the next five years. Public spending on health was 0·94% of the gross domestic product (GDP) in 2004–05, which was among the lowest in the world. Private expenditure on health in India is about 78% as compared to 14% in the Maldives, Bhutan (29%), Sri Lanka (53%), Thailand (31%) and China (61%). Union health minister Ghulam Nabi Azad on...
More »One less mouth to feed by Shyamal Majumdar
A fortnight ago, Moin was beaten to death by his uncle who was the owner of the factory where the 10-year-old worked. Very few would have cared but for television, which brought the horrific images of his battered body into middle-class living rooms. But it’s doubtful if anybody would remember Moin’s tragedy once the TV cameras shift elsewhere. This has happened many times. Just a year ago, an engineer couple was...
More »MNC may need govt nod to buy local pharma firm by Khomba Singh
The government may approve acquisitions of local drugmakers by global firms on a case-by-case basis on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions on such deals in the wake of a spate of takeovers in the last three years. Multinationals may have to move buyout proposals through the Foreign Investment Promotion Board (FIPB), allowing the government to understand the firm's rationale for buying a...
More »